bf/NASDAQ:CYTK_icon.png

COM:CYTOKINETICS

Cytokinetics, Incorporated

  • Stock

Last Close

47.67

22/11 21:00

Market Cap

6.30B

Beta: -

Volume Today

1.44M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-3.39M
-
-3.39M
0%
-2.21M
34.86%
-28.12M
1,172.38%
-25.98M
7.60%
-73.50K
99.72%
average payables
2.93M
-
2.54M
13.50%
1.80M
29.01%
3.24M
79.88%
4.74M
46.57%
4.51M
4.97%
5.96M
32.24%
8.11M
35.94%
14.57M
79.75%
23.35M
60.27%
23.56M
0.90%
average receivables
4.50K
-
23.33M
518,244.44%
23.33M
0.02%
18K
99.92%
568K
3,055.56%
3.95M
595.16%
5.97M
51.30%
4.79M
19.79%
28.12M
486.86%
25.98M
7.60%
715K
97.25%
book value per share
2.00
-
2.58
29.16%
1.77
31.46%
2.36
33.68%
2.22
5.89%
0.48
78.57%
-0.19
139.86%
1.76
1,025.04%
3.17
80.50%
-1.20
137.87%
-4.00
233.19%
capex per share
-0.02
-
-0.03
55.58%
-0.01
53.17%
-0.04
175.96%
-0.06
45.74%
-0.02
71.95%
-0.05
178.46%
-0.17
276.55%
-0.64
271.10%
-0.13
80.15%
-0.01
88.37%
capex to depreciation
-1.25
-
-2.25
80.00%
-0.95
57.65%
-2.15
125.73%
-1.50
30.43%
-0.72
52.12%
-2.03
182.30%
-6.04
198.00%
-21.47
255.74%
-1.95
90.92%
-0.12
93.89%
capex to operating cash flow
0.07
-
0.02
64.94%
-0.12
567.49%
-0.04
62.50%
0.03
165.51%
0.01
68.93%
0.03
228.01%
-1.24
4,389.63%
0.34
127.75%
0.04
88.96%
0.00
90.97%
capex to revenue
-0.02
-
-0.02
32.99%
-0.02
16.62%
-0.01
23.52%
-0.22
1,334.86%
-0.03
86.89%
-0.10
245.40%
-0.20
103.09%
-0.69
250.53%
-0.12
82.73%
-0.19
56.92%
cash per share
2.85
-
2.33
18.21%
2.87
23.19%
3.91
36.24%
5.44
39.14%
3.65
32.90%
3.91
7.07%
7.19
83.95%
6.13
14.71%
8.71
42.03%
6.37
26.89%
days of inventory on hand
-27.78
-
-16.64
-
-118.26
610.67%
-0.22
99.81%
days payables outstanding
27.38
-
11.18
59.16%
17.61
57.45%
25.81
46.62%
21.23
17.74%
15.41
27.41%
34.58
124.37%
30.31
12.36%
48.12
58.79%
38.82
19.34%
days sales outstanding
0.06
-
362.71
609,020.84%
0.15
99.96%
0.08
46.14%
30.36
36,780.54%
78.62
158.93%
70.14
10.78%
28.90
58.80%
268.56
829.34%
0.57
99.79%
62.19
10,863.53%
debt to assets
-0.04
-
-0.01
77.04%
0.11
1,151.37%
0.18
63.20%
0.09
48.77%
0.20
123.23%
0.47
133.77%
0.26
44.56%
0.32
23.27%
0.74
130.15%
0.85
14.57%
debt to equity
-0.07
-
-0.01
78.30%
0.18
1,323.00%
0.32
75.15%
0.24
23.75%
1.64
577.27%
-12.44
860.73%
1.23
109.85%
1.11
9.67%
-6.94
727.41%
-1.81
74.01%
dividend yield
earnings yield
-0.19
-
-0.05
73.08%
-0.09
80.39%
0.03
136.70%
-0.32
1,036.16%
-0.31
2.63%
-0.24
21.05%
-0.12
49.83%
-0.07
43.50%
-0.10
41.42%
-0.07
33.24%
enterprise value
157.13M
-
265.81M
69.17%
355.56M
33.76%
445.81M
25.38%
309.21M
30.64%
344.09M
11.28%
710.51M
106.49%
1.40B
96.59%
3.66B
162.16%
4.80B
31.07%
8.64B
80.08%
enterprise value over ebitda
-4.64
-
-18.02
288.63%
-9.51
47.24%
23.86
350.99%
-2.79
111.70%
-4.06
45.52%
-7.64
88.04%
-15.76
106.40%
-19.69
24.91%
-15.34
22.08%
-16.42
7.06%
ev to operating cash flow
-20.36
-
-5.93
70.88%
72.82
1,328.40%
12.05
83.44%
-3.04
125.21%
-3.40
11.88%
-7.82
129.90%
156.18
2,098.34%
-25.69
116.45%
-16.02
37.63%
-20.86
30.18%
ev to sales
5.13
-
5.66
10.45%
12.41
119.09%
4.19
66.23%
23.13
452.09%
10.92
52.78%
26.44
142.09%
25.02
5.39%
51.99
107.81%
50.74
2.41%
1.15K
2,162.11%
free cash flow per share
-0.30
-
-1.29
324.88%
0.11
108.65%
0.89
695.78%
-2.12
339.07%
-1.88
11.41%
-1.62
13.42%
-0.03
97.99%
-2.49
7,515.98%
-3.46
39.02%
-4.31
24.46%
free cash flow yield
-0.05
-
-0.16
244.78%
0.01
106.63%
0.07
585.09%
-0.26
456.41%
-0.30
14.24%
-0.15
48.43%
-0.00
98.97%
-0.05
3,372.14%
-0.08
38.29%
-0.05
31.69%
graham net net
1.80
-
2.16
20.54%
1.67
22.88%
2.02
20.69%
1.72
14.86%
0.28
83.74%
-1.25
546.77%
0.69
155.63%
-1.47
311.68%
-3.79
157.90%
-6.16
62.78%
graham number
7.45
-
4.88
34.54%
6.20
27.07%
4.68
24.51%
11.38
143.10%
4.58
59.77%
3.33
27.31%
10.03
201.49%
15.00
49.56%
11.01
26.62%
22.16
101.33%
income quality
0.23
-
3.06
1,237.58%
-0.13
104.25%
2.25
1,826.24%
0.80
64.57%
0.95
19.59%
0.75
21.55%
-0.07
109.40%
0.66
1,042.15%
0.77
16.34%
0.79
2.24%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
191.49
-
136.61
28.66%
-397.95
391.30%
8.36
102.10%
-6.67
179.76%
-4.12
38.20%
-3.61
12.36%
-2.43
32.78%
-6.35
161.50%
-6.34
0.23%
18.59
393.35%
interest debt per share
-0.14
-
-0.04
71.13%
0.32
882.53%
0.80
149.76%
0.88
9.56%
1.18
33.46%
2.84
141.45%
2.75
3.02%
3.89
41.40%
8.91
128.96%
6.93
22.22%
inventory turnover
-13.14
-
-21.93
-
-3.09
85.93%
-1.64K
52,976.22%
invested capital
-0.07
-
-0.01
78.30%
0.18
1,323.00%
0.32
75.15%
0.24
23.75%
1.64
577.27%
-12.44
860.73%
1.23
109.85%
1.11
9.67%
-6.94
727.41%
-1.81
74.01%
market cap
177.29M
-
286.03M
61.34%
405.99M
41.94%
485.31M
19.54%
402.64M
17.03%
343.93M
14.58%
610.87M
77.61%
1.34B
119.49%
3.50B
161.37%
4.12B
17.44%
8.06B
95.80%
net current asset value
50.59M
-
90.23M
78.34%
66.46M
26.34%
82.85M
24.66%
89.33M
7.82%
22.43M
74.89%
-67.00M
398.70%
53.80M
180.30%
-61.78M
214.84%
-327.49M
430.05%
-582.59M
77.90%
net debt to ebitda
0.59
-
1.37
130.38%
1.35
1.59%
-2.11
256.74%
0.84
139.90%
-0.00
100.22%
-1.07
57,690.81%
-0.63
41.04%
-0.85
33.92%
-2.19
158.46%
-1.11
49.19%
net income per share
-1.24
-
-0.41
66.82%
-0.97
135.57%
0.41
142.63%
-2.59
727.96%
-1.95
24.49%
-2.59
32.55%
-2.54
1.74%
-3.15
23.92%
-4.48
42.17%
-5.45
21.65%
operating cash flow per share
-0.28
-
-1.26
343.79%
0.13
110.02%
0.93
635.96%
-2.06
322.46%
-1.86
9.70%
-1.58
15.11%
0.14
108.78%
-1.85
1,437.44%
-3.33
79.88%
-4.29
28.73%
payables turnover
13.33
-
32.64
144.83%
20.73
36.49%
14.14
31.80%
17.19
21.57%
23.68
37.76%
10.55
55.43%
12.04
14.11%
7.58
37.02%
9.40
23.97%
receivables turnover
6.13K
-
1.01
99.98%
2.39K
237,220.88%
4.43K
85.65%
12.02
99.73%
4.64
61.38%
5.20
12.09%
12.63
142.71%
1.36
89.24%
643.46
47,243.72%
5.87
99.09%
research and ddevelopement to revenue
1.61
-
0.95
41.34%
1.62
71.06%
0.56
65.23%
6.75
1,099.96%
2.83
58.11%
3.21
13.28%
1.74
45.82%
2.27
30.77%
0.07
96.93%
0.54
668.41%
return on tangible assets
-0.41
-
-0.11
72.82%
-0.33
195.45%
0.10
129.72%
-0.43
548.25%
-0.50
16.11%
-0.51
2.18%
-0.31
40.21%
-0.29
6.31%
-0.40
37.70%
-0.64
60.93%
revenue per share
1.12
-
1.31
16.98%
0.74
43.83%
2.66
260.80%
0.27
89.84%
0.58
113.92%
0.47
19.38%
0.87
85.41%
0.92
5.87%
1.05
14.96%
0.08
92.59%
roe
-0.62
-
-0.16
74.31%
-0.55
243.68%
0.17
131.89%
-1.16
767.23%
-4.10
252.28%
13.63
432.52%
-1.45
110.62%
-0.99
31.34%
3.73
475.38%
1.36
63.49%
roic
-0.66
-
-0.16
76.16%
-0.45
189.16%
0.16
134.57%
-0.84
631.86%
-1.35
61.75%
-0.92
32.13%
-0.47
48.35%
-0.33
30.97%
-0.43
31.26%
-1.17
172.63%
sales general and administrative to revenue
0.49
-
0.37
25.29%
0.69
86.55%
0.26
61.90%
2.73
943.31%
0.99
63.60%
1.47
48.46%
0.95
35.82%
1.37
45.28%
1.88
36.89%
23.06
1,125.34%
shareholders equity per share
2.00
-
2.58
29.16%
1.77
31.46%
2.36
33.68%
2.22
5.89%
0.48
78.57%
-0.19
139.86%
1.76
1,025.04%
3.17
80.50%
-1.20
137.87%
-4.00
233.19%
stock based compensation to revenue
0.12
-
0.07
39.55%
0.16
124.64%
0.07
57.86%
0.68
905.62%
0.31
54.12%
0.40
29.23%
0.32
21.18%
0.38
20.71%
0.51
32.79%
9.57
1,791.72%
tangible asset value
54.44M
-
92.06M
69.10%
68.59M
25.50%
94.36M
37.57%
109.84M
16.41%
25.93M
76.39%
-10.94M
142.17%
113.38M
1,136.69%
243.86M
115.08%
-107.90M
144.25%
-386.32M
258.04%
tangible book value per share
2.00
-
2.58
29.16%
1.77
31.46%
2.36
33.68%
2.22
5.89%
0.48
78.57%
-0.19
139.86%
1.76
1,025.04%
3.17
80.50%
-1.20
137.87%
-4.00
233.19%
working capital
52.63M
-
107.28M
103.82%
81.46M
24.07%
125.38M
53.91%
241.85M
92.90%
185.48M
23.31%
207.73M
12.00%
443.02M
113.27%
463.81M
4.69%
710.57M
53.20%
525.37M
26.06%

All numbers in (except ratios and percentages)